Caspofungin 50mg powder for solution for infusion vials
NHS hospitals in England used £15,744,992 of indicative cost of Caspofungin 50mg powder for solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 2.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Caspofungin 50mg powder for solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Caspofungin 50mg powder for solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £1,157,325 |
| The Royal Marsden Nhs Foundation Trust | £895,285 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £800,215 |
| University College London Foundation Tr | £663,810 |
| Univ Hpl B/Ham Nhs Foundation Trust | £639,694 |
| The Clatterbridge Cancer Centre Nhs Ft | £547,251 |
| Imperial College Healthcare Nhs Trust | £477,979 |
| Royal Free London Nhs Foundation Trust | £412,290 |
| Barts Health Nhs Trust | £398,674 |
| Aintree University Hospital Nhs Ft | £376,698 |
The primary-care picture
Caspofungin is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Caspofungin medicine page.